Live Breaking News & Updates on Martin Vogel

Stay updated with breaking news from Martin vogel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Erdafitinib for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer with Susceptible FGFR Alterations

Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Erdafitinib for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer with Susceptible FGFR Alterations
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Region Flamande , Kiran Patel , Tanakam Sonpavde , Janssen Cilag Gmb , Martin Vogel , Janssen Pharmaceutica , Drug Administration , American Society Of Clinical Oncology , Janssen Research Development In Phase , Astex Therapeutics , Astex Pharmaceuticals , Janssen Pharmaceutical Companies , European Medicines Agency , Clinical Development , Astex Announces New Drug Discovery Alliance , Companies Of Johnson , None Of The Janssen Pharmaceutical Companies , Janssen Research Development , Janssen Pharmaceutical Companies Of Johnson , Late Breaking Presentation Session , Marketing Authorisation Application , Area Lead Oncology , Clinical Oncology , Vice President , Solid Tumors ,

Janssen's Erdafitinib 'significantly extends' survival of urothelial cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson announced its drug Erdafitinib extends survival in bladder cancer. ....

France General , Institut Gustave Roussy , Yohann Loriot , Janssen Cilag Gmb , Martin Vogel , Eastern Cooperative Oncology Group , University Of Paris , Janssen Cilag Gmbh , Clinical Development , Pis Active Pharmaceutical Ingredients , Phase Iii Iv , Bladder Cancer , Clinical Trial , Clinical Research , Pharmaceutical Industry ,

Janssen reveals data from erdafitinib study

Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma - News - PharmaTimes ....

France General , Janssen Cilag Gmb , Yohann Loriot , Martin Vogel , University Of Paris , Janssen Pharmaceutical Companies Of Johnson , Janssen Pharmaceutical Companies , Janssen Cilag Gmbh ,

Janssen shares positive phase 3 results for erdafitinib in bladder cancer

Janssen shares positive phase 3 results for erdafitinib in bladder cancer
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United States , Janssen Cilag Gmb , Martin Vogel , Janssen Pharmaceutical Companies Of Johnson , American Society Of Clinical Oncology , Drug Administration , Janssen Pharmaceutical Companies , Janssen Cilag Gmbh , American Society , Clinical Oncology ,

New Long-Term Data from the CHRYSALIS Study Show Median

Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung cancer who have a MET positive. ....

United States , Region Flamande , Noord Holland , South Korea , Janssen Cilag Gmb , Martin Vogel , Hoon Lee , Kiran Patel , National Cancer Institute , Janssen Pharmaceutical Companies , American Society Of Clinical Oncology , Samsung Medical Center , European Commission , Exchange Commission , Yuhan Corporation , Companies Of Johnson , European Union , American Society For Clinical Oncology Annual Meeting , European Medicines Agency , None Of The Janssen Pharmaceutical Companies , Sungkyunkwan University School Of Medicine , American Lung Association , Janssen Biotech Inc , Drug Administration , Clinical Development , Janssen Research ,